David Shaw’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
David Shaw's LKFT Position: Q3 2026 in Review
David Shaw increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 65% in Q3 2026, buying an estimated $3.66M and bringing the position to 325,660 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.
David Shaw first reported a position in LKFT in Q3 2018 and has held it in 28 quarters since. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- David Shaw held 325,660 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.7M as of Q3 2026.
- David Shaw bought 127,816 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $3.66M.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #1838 holding.
- David Shaw first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 28 quarters since.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.